Association of prediabetes with diffuse coronary narrowing and small-vessel disease

Journal of Cardiology

Volumn 63, Issue 1, 2014, Pages 29-34

  Ertan, Cagatay ^a   Ozeke, Ozcan ^b   Gul, Murat ^b   Aras, Dursun ^b   Topaloglu, Serkan ^b   Kisacik, Halil Lutfi ^b   Demir, Ahmet Duran ^a   Aydogdu, Sinan ^b   Ozin, Bulent ^c  

^a ACIBADEM UNIVERSITY   (Turkey)

^b TURKIYE YUKSEK IHTISAS HOSPITAL   (Turkey)

^c BASKENT UNIVERSITY   (Turkey)

Author keywords

Coronary artery size; Diffuse coronary narrowing; Prediabetes

Indexed keywords

CREATININE; GLUCOSE; HEMOGLOBIN A1C;

ADULT; AGED; ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CREATININE BLOOD LEVEL; DIABETIC PATIENT; DISEASE ASSOCIATION; FEMALE; GENSINI SCORE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PROSPECTIVE STUDY; SMALL CORONARY ARTERIAL SIZE;

CORONARY ARTERY SIZE; DIFFUSE CORONARY NARROWING; PREDIABETES;

AGED; CORONARY ARTERY DISEASE; CORONARY VESSELS; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL REVASCULARIZATION; PREDIABETIC STATE; PROSPECTIVE STUDIES;

EID: 84891902615     PISSN: 09145087     EISSN: 18764738     Source Type: Journal    
DOI: 10.1016/j.jjcc.2013.06.015     Document Type: Article

References (49)

1. Rydén L., Standl E., Bartnik M., Van den Berghe G., Betteridge J., de Boer M.J., Cosentino F., Jönsson B., Laakso M., Malmberg K., Priori S., Ostergren J., Tuomilehto J., Thrainsdottir I., Vanhorebeek I., et al. Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC); European Association for the Study of Diabetes (EASD). Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur Heart J 2007, 28:88-136.
2. American Diabetes Association Diagnosis and classification of diabetes mellitus. Diabetes Care 2010, 33:S62-S69.
3. Gerstein H.C., Santaguida P., Raina P., Morrison K.M., Balion C., Hunt D., Yazdi H., Booker L. Annual incidence and relative risk of diabetes in people with various categories of dysglycemia: a systematic overview and meta-analysis of prospective studies. Diabetes Res Clin Pract 2007, 78:305-312.
4. Shaw J., Zimmet P., de Courten M., Dowse G., Chitson P., Gareeboo H., Hemraj F., Fareed D., Tuomilehto J., Alberti K. Impaired fasting glucose or impaired glucose tolerance. What best predicts future diabetes in Mauritiusα. Diabetes Care 1999, 22:399-402.
5. Tirosh A., Shai I., Tekes-Manova D., Israeli E., Pereg D., Shochat T., Kochba I., Rudich A., Israeli Diabetes Research Group Normal fasting plasma glucose levels and type 2 diabetes in young men. N Engl J Med 2005, 353:1454-1462.
6. Mercurio V., Carlomagno G., Fazio V., Fazio S. Insulin resistance: is it time for primary preventionα. World J Cardiol 2012, 4:1-7.
7. Mellbin L.G., Anselmino M., Rydén L. Diabetes, prediabetes and cardiovascular risk. Eur J Cardiovasc Prev Rehabil 2010, 17(Suppl. 1):S9-S14.
8. Uddin S.N., Malik F., Bari M.A., Siddiqui N.I., Khan G.K., Rahman S., Sadequzzaman M. Angiographic severity and extent of coronary artery disease in patients with type 2 diabetes mellitus. Mymensingh Med J 2005, 14:32-37.
9. Kip K.E., Faxon D.P., Detre K.M., Yeh W., Kelsey S.F., Currier J.W. Coronary angioplasty in diabetic patients. The national heart, lung, and blood institute percutaneous transluminal coronary angioplasty registry. Circulation 1996, 94:1818-1825.
10. Aronson D., Edelman E.R. Revascularization for coronary artery disease in diabetes mellitus: angioplasty, stents and coronary artery bypass grafting. Rev Endocr Metab Disord 2010, 11:75-86.
11. Sugihara M., Miura S., Nishikawa H., Ike A., Mori K., Iwata A., Kawamura A., Saku K. Characteristics of patients and types of lesions in patients with drug-eluting or bare-metal stent implantation in small coronary arteries: from the FU-Registry. J Cardiol 2013, 61:117-121.
12. Aboyans V., Lacroix P., Criqui M.H. Large and small vessels atherosclerosis: similarities and differences. Prog Cardiovasc Dis 2007, 50:112-125.
13. De Luca G., Suryapranata H., de Boer M.J., Ottervanger J.P., Hoorntje J.C., Gosselink A.T., Dambrink J.H., van't Hof A.W. Impact of vessel size on distal embolization, myocardial perfusion and clinical outcome in patients undergoing primary angioplasty for ST-segment elevation myocardial infarction. J Thromb Thrombolysis 2009, 27:198-203.
14. Kim J.B., Kang J.W., Song H., Jung S.H., Choo S.J., Chung C.H., Lee J.W., Lim T.H. Late improvement in graft patency after coronary artery bypass grafting: Serial assessment with multidetector computed tomography in the early and late postoperative settings. J Thorac Cardiovasc Surg 2011, 142:793-799.
15. McLean R.C., Nazarian S.M., Gluckman T.J., Schulman S.P., Thiemann D.R., Shapiro E.P., Conte J.V., Thompson J.B., Shafique I., McNicholas K.W., Villines T.C., Laws K.M., Rade J.J. Relative importance of patient, procedural and anatomic risk factors for early vein graft thrombosis after coronary artery bypass graft surgery. J Cardiovasc Surg (Torino) 2011, 52:877-885.
16. Zindrou D., Taylor K.M., Bagger J.P. Coronary artery size and disease in UK South Asian and Caucasian men. Eur J Cardiothorac Surg 2006, 29:492-495.
17. O'Connor N.J., Morton J.R., Birkmeyer J.D., Olmstead E.M., O'Connor G.T. Effect of coronary artery diameter in patients undergoing coronary bypass surgery Northern New England Cardiovascular Disease Study Group. Circulation 1996, 93:652-655.
18. Biondi-Zoccai G.G., Sangiorgi G.M., Antoniucci D., Di Mario C., Reimers B., Tamburino C., Agostoni P., Cosgrave J., Colombo A. Taxus in Real-life Usage Evaluation Study Testing prospectively the effectiveness and safety of paclitaxel-eluting stents in over 1000 very high-risk patients: design, baseline characteristics, procedural data and in-hospital outcomes of the multicenter Taxus in Real-life Usage Evaluation (TRUE) Study. Int J Cardiol 2007, 117:349-354.
19. Peterson E.D., Lansky A.J., Kramer J., Peterson E.D., Lansky A.J., Kramer J., Anstrom K., Lanzilotta M.J. National Cardiovascular Network Clinical Investigators Effect of gender on the outcomes of contemporary percutaneous coronary intervention. Am J Cardiol 2001, 88:359-364.
20. O'Connor G.T., Morton J.R., Diehl M.J., Olmstead E.M., O'Connor G.T. Differences between men and women in hospital mortality associated with coronary artery bypass graft surgery. The Northern New England Cardiovascular Disease Study Group. Circulation 1993, 88:2104-2110.
21. Yang F., Minutello R.M., Bhagan S., Sharma A., Wong S.C. The impact of gender on vessel size in patients with angiographically normal coronary arteries. J Interv Cardiol 2006, 19:340-344.
22. Fisher L.D., Kennedy J.W., Davis K.B., Maynard C., Fritz J.K., Kaiser G., Myers W.O. Association of sex, physical size, and operative mortality after coronary artery bypass in the Coronary Artery Surgery Study (CASS). J Thorac Cardiovasc Surg 1982, 84:334-341.
23. Alexander C.M., Landsman P.B., Teutsch S.M. Diabetes mellitus, impaired fasting glucose, atherosclerotic risk factors, and prevalence of coronary heart disease. Am J Cardiol 2000, 86:897-902.
24. Scognamiglio R., Negut C., Ramondo A., Tiengo A., Avogaro A. Detection of coronary artery disease in asymptomatic patients with type 2 diabetes mellitus. J Am Coll Cardiol 2006, 47:65-71.
25. Mosseri M., Nahir M., Rozenman Y., Lotan C., Admon D., Raz I., Gotsman M.S. Diffuse narrowing of coronary arteries in diabetic patients: the earliest phase of coronary artery disease. Cardiology 1998, 89:103-110.
26. Briguori C., Tobis J., Nishida T., Vaghetti M., Albiero R., Di Mario C., Colombo A. Discrepancy between angiography and intravascular ultrasound when analysing small coronary arteries. Eur Heart J 2002, 23:247-254.
27. Vassalli G., Hess O.M., Krogmann O.N., Villari B., Corin W.J., Turina M., Krayenbuehl H.P. Coronary artery size in mitral regurgitation and its regression after mitral valve surgery. Am Heart J 1993, 126:1091-1098.
28. Villari B., Hess O.M., Moccetti D., Vassalli G., Krayenbuehl H.P. Effect of progression of left ventricular hypertrophy on coronary artery dimensions in aortic valve disease. J Am Coll Cardiol 1992, 20:1073-1079.
29. Kimball B.P., LiPreti V., Bui S., Wigle E.D. Comparison of proximal left anterior descending and circumflex coronary artery dimensions in aortic valve stenosis and hypertrophic cardiomyopathy. Am J Cardiol 1990, 65:767-771.
30. Dodge J.T., Brown B.G., Bolson E.L., Dodge H.T. Lumen diameter of normal human coronary arteries Influence of age, sex, anatomic variation, and left ventricular hypertrophy or dilation. Circulation 1992, 86:232-246.
31. Dickerson J.A., Nagaraja H.N., Raman S.V. Gender-related differences in coronary artery dimensions: a volumetric analysis. Clin Cardiol 2010, 33:E44-E49.
32. Davidson M.H., Plutzky J. The role of cardiologists in the management of patients with diabetes is evolving owing to the close relationship between diabetes and CAD. Introduction. Am J Cardiol 2011, 108:1B-2B.
33. Parikh S.V., Luna M., Selzer F., Marroquin O.C., Mulukutla S.R., Abbott J.D., Holper E.M. Outcomes of small coronary artery stenting with bare-metal stents vs. drug-eluting stents: results from the NHLBI dynamic registry. Catheter Cardiovasc Interv 2011, Jul 6 [Epub ahead of print]. 10.1002/ccd.23194.
34. Tuomilehto J., Lindström J., Eriksson J.G., Valle T.T., Hämäläinen H., Ilanne-Parikka P., Keinänen-Kiukaanniemi S., Laakso M., Louheranta A., Rastas M., Salminen V., Uusitupa M., Finnish Diabetes Prevention Study Group Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001, 344:1343-1350.
35. Grundy S.M. Prediabetes, metabolic syndrome, and cardiovascular risk. J Am Coll Cardiol 2012, 59:635-643.
36. Ford E.S., Zhao G., Li C. Pre-diabetes and the risk for cardiovascular disease: a systematic review of the evidence. J Am Coll Cardiol 2010, 55:1310-1317.
37. Harris M.I., Klein R., Welborn T.A., Knuiman M.W. Onset of NIDDM occurs at least 4-7 yr before clinical diagnosis. Diabetes Care 1992, 13:815-819.
38. UK Prospective Diabetes Study Group Study design, progress and performance. Diabetologia 1991, 34:877-890.
39. Tsugawa Y., Mukamal K.J., Davis R.B., Taylor W.C., Wee C.C. Should the hemoglobin A1c diagnostic cutoff differ between blacks and whitesα A cross-sectional study. Ann Intern Med 2012, 157:153-159.
40. Hu F.B., Stampfer M.J., Haffner S.M., Solomon C.G., Willett W.C., Manson J.E. Elevated risk of cardiovascular disease prior to clinical diagnosis of type 2 diabetes. Diabetes Care 2002, 25:1129-1134.
41. Haffner S.M., Stern M.P., Hazuda H.P., Mitchell B.D., Patterson J.K. Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetesα. JAMA 1990, 263:2893-2898.
42. Kadi H., Ceyhan K., Karayakali M., Celik A., Ozturk A., Koc F., Onalan O. Effects of prediabetes on coronary collateral circulation in patients with coronary artery disease. Coron Artery Dis 2011, 22:233-237.
43. Wang H., Hu B., Lu W., Liu F., Feng B. Relationship of angiographically defined coronary artery disease with insulin sensitivity and secretion in subjects with different glucose tolerance. J Cardiol 2012, 60:367-371.
44. Heianza Y., Hara S., Arase Y., Saito K., Fujiwara K., Tsuji H., Kodama S., Hsieh S.D., Mori Y., Shimano H., Yamada N., Kosaka K., Sone H. HbA1c 5.7-6.4% and impaired fasting plasma glucose for diagnosis of prediabetes and risk of progression to diabetes in Japan (TOPICS 3): a longitudinal cohort study. Lancet 2011, 378:147-155.
45. Kumaravel B., Bachmann M.O., Murray N., Dhatariya K., Fenech M., John W.G., Scarpello T.J., Sampson M.J., on behalf of the University of East Anglia Impaired Fasting Glucose (UEA-IFG) Study Group Use of haemoglobin A1c to detect impaired fasting glucose or type 2 diabetes in a United Kingdom community based population. Diabetes Res Clin Pract 2012, 96:211-216.
46. Olson D.E., Ziemer D.C., Rhee M.K., Twombly J.G., Herrick K., Phillips L.S. Screening for diabetes and pre-diabetes with proposed A1c-based diagnostic criteria. Diabetes Care 2010, 33:2184-2189.
47. Manley S.E., Sikaris K.A., Lu Z.X., Nightingale P.G., Stratton I.M., Round R.A., Baskar V., Gough S.C., Smith J.M. Validation of an algorithm combining hemoglobin A1c and fasting plasma glucose for diagnosis of diabetes mellitus in UK and Australian populations. Diabet Med 2009, 26:115-121.
48. Sheifer S.E., Canos M.R., Weinfurt K.P., Arora U.K., Mendelsohn F.O., Gersh B.J., Weissman N.J. Sex differences in coronary artery size assessed by intravascular ultrasound. Am Heart J 2000, 139:649-653.
49. Seiler C., Kirkeeide R.L., Gould K.L. Basic structure-function relations of the epicardial coronary vascular tree Basis of quantitative coronary arteriography for diffuse coronary artery disease. Circulation 1992, 85:1987-2003.